Month: June 2020

Bannockburn, IL, June 22, 2020 (GLOBE NEWSWIRE) — (“Veroni” or the “Company”) (OTCBB:VONI), an importer of premium beverage, chocolate and snack products produced in Europe, which sells and distributes to domestic and international retailers, has received approval from the Financial Industry Regulatory Authority (“FINRA”) to quote and trade the Company’s securities on the OTC Markets.The Company has satisfied the requirements of Rule 15c2-11 and has been assigned the trading symbol OTCBB: VONI, enabling the Company’s Market Maker to quote the Company’s securities on the Over-the-Counter Bulletin Board. The Company is now within the regulatory 30-day time frame to be cleared for other market makers to participate.Igor Gabal, President and CEO, stated, “This marks a significant milestone in the rapid growth of Veroni Brands. ...

TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — Silver Bear Resources Plc (“Silver Bear” or the “Company”) (TSX: SBR) announces that it has now received a draft report from Wardell Armstrong (Moscow) that provides a review of the Company’s current mineral resources, as well as draft revised mine and processing plans, for its Vertikalny and Mangazeisky North deposits (“Draft WA Report”). Silver Bear had previously disclosed that it had engaged Wardell Armstrong (Moscow) to conduct this review of the mineral resources as well as revised mine and processing plans for these deposits.The Draft WA Report presents a potential material change to the current mineral resources at these deposits. Given the potential material changes to the mineral resource estimates for both Vertikalny and Mangazeisky North deposits and the scope of the project...

Piraeus, Greece, June 22, 2020 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog” or “the Company”) (NYSE: GLOG) today announced that the company has sold 14,400,000 common shares at a price of $2.50 per share for total gross proceeds of $36.0 million through a private placement of unregistered common shares (the “Private Placement”). The net proceeds of the Private Placement are expected to be used for general corporate purposes. Approximately 75% of shares issued in the Private Placement were purchased by GasLog’s directors and affiliates, including 6,500,000 common shares purchased by Blenheim Holdings Ltd, wholly owned by the Livanos family and 4,000,000 common shares purchased by a wholly owned affiliate of the Onassis Foundation. In addition, members of the Tung family, whose roots in shipping date back over 70 years, purchased common...

LONG BEACH, NY and ESSENDON, AUSTRALIA, June 22, 2020 (GLOBE NEWSWIRE) — Ipsidy Inc. (www.ipsidy.com) [OTCQB: IDTY], a leading provider of secure, mobile biometric identity solutions, including Identity as a Service (IDaaS) and PharmacyID, (www.pharmacyid.com.au) which operates a platform offering a trusted identity verification service through a network of over 2,500 pharmacies, have signed a partnership agreement to create an identity verification solution, with the highest level of assurance for the Australian market.PharmacyID has over twenty years of experience in Australia and is accredited by the Australian Criminal Intelligence Commission (ACIC) to provide Police background check services and the Department of Home Affairs, Document Verification Service (DVS). PharmacyID seeks to enhance its current customer identity verification...

TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — Compass Gold Corp. (TSX-V: CVB) (Compass or the Company) is pleased to provide an update on the recently completed drilling at the Samagouela and Samagouela South prospects, located on the Company’s Kourou permit within the Sikasso Property in Southern Mali (Figure 1).HighlightsGeophysical survey and drilling at Samagouela identify a pronounced, broad, shallow gold target, associated with a shear zone, extending more than 2-kilometresAir core drilling (24 AC holes, 1,253 m) intersects gold mineralization within two wide trendsBest interval at Samagouela: 9 m at 5.79 g/t Au (from 45 m, and remains open at depth), including 1 m @ 36.37 g/t Au (from 45m)Best interval at Samagouela South: 14 m at 2.75 g/t Au (from 20 m), including 1 m @ 11.64 g/t Au (from 21 m)Further geophysical testing planned...

Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptorCurcumin shows increased anticancer activity when conjugated to proprietary peptideSORT1+ technology significantly widens therapeutic window of traditional cytotoxic cancer treatmentsMONTREAL, June 22, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that new data featuring its investigational sortilin 1 (SORT1)-targeting peptide-drug conjugate technology will be presented in three posters at the American Association for Cancer Research’s virtual annual meeting II.“We believe that our SORT1+ technology is one of the most promising advances in the treatment of cancer in many years....

Inhibition significative du mimétisme vasculogénique observée avec le TH1902 et le TH1904Activité anticancéreuse accrue de la curcumine conjuguée avec un peptide exclusifLa technologie SORT1+ élargit significativement la fenêtre thérapeutique des traitements cytotoxiques traditionnels du cancerMONTRÉAL, 22 juin 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), une société biopharmaceutique commerciale, a le plaisir d’annoncer que de nouvelles données sur ses conjugués peptide-médicament (PCM) expérimentaux ciblant la sortiline (SORT1) feront l’objet de trois affiches qui seront présentées lors du congrès annuel virtuel II de l’American Association for Cancer Research (AACR).« Nous croyons que la technologie SORT1+ est un des progrès les plus prometteurs dans le traitement du cancer depuis...

REDWOOD CITY, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer targets, today announced dosing of the first patient in a multicenter Phase 1 clinical trial evaluating the combination of RMC-4630 (SAR442720), the company’s investigational SHP2 inhibitor, and pembrolizumab (Keytruda®), an anti-PD-1 antibody. The trial, which is being sponsored and conducted by the company’s collaboration partner Sanofi, is an open-label, safety, preliminary efficacy and pharmacokinetics study in participants with advanced malignancies. This will include patients with non-small cell lung cancer (NSCLC) who have progressed on or after platinum-based chemotherapy, and patients with colorectal cancer who have progressed...

PV-10 treatment leads to STING dimerizationResearchers identify potential association of heat shock proteins with STING in PV-10-treated modelsKNOXVILLE, TN, June 22, 2020 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today is pleased to announce that data from ongoing preclinical study of investigational autolytic cancer immunotherapy PV-10 (rose bengal disodium) is being presented at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II, held online June 22-24, 2020. This PV-10 research has been led by Aru Narendran, MD, PhD and his team of researchers at the University of Calgary in Alberta, Canada (UCalgary).Dr. Narendran and his colleagues studied the effects of PV-10 treatment on primary cells and cell lines derived from pediatric leukemia patients. UCalgary showed that PV-10 treatment led to STING...

COLUMBIA, Md., June 22, 2020 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ:REKR) (“Rekor”) (“the Company”), a Maryland-based company providing real-time roadway intelligence through AI-driven decisions, today announced that the U.S. Department of Defense (DOD) has authorized $160,000 for the purchase of the Company’s vehicle recognition software. These licenses will allow Rekor’s AI-powered vehicle recognition software to be deployed quickly to existing cameras to support national security efforts.“When it comes to national security, the Department of Defense has exacting standards,” said Robert A. Berman, President and CEO, Rekor. “Knowing the wide range of solutions they have at their disposal, we are pleased they are continuing to expand their use of Rekor’s best-in-class, machine learning and artificial intelligence-based...